Balance Sheet DiaSorin S.p.A.

Stocks

DIA

IT0003492391

Medical Equipment, Supplies & Distribution

Real-time Borsa Italiana Other stock markets 12:02:40 12/06/2026 BST			5-day change	1st Jan Change
68.62 ^EUR	+0.18%		-3.92%	-

06-11	Piper Sandler Begins Diasorin Coverage with Neutral Rating	MT
06-08	MPS catalyzes banking M&A wave and drives MIB higher	AN

199a27e6876.ytiLAWBE7uawIovUldWny1FmD-JZ2r9v890zmUYI2d0.m4C6dgggi4vzbL6R3ZyQpT8yWKUamOowirJw6hNMk7Kpr8VKVhemvspF2g

Published financial data: DIASORIN S.P.A.

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: December	2021	2022	2023	2024	2025
Revenues	1.24B	1.36B	1.15B	1.19B	1.2B
Total Revenues	1.24B	1.36B	1.15B	1.19B	1.2B
Cost of Goods Sold, Total	413M	461M	407M	403M	418M
Gross Profit	825M	901M	741M	782M	778M
Selling General & Admin Expenses, Total	305M	415M	414M	415M	408M
R&D Expenses	70.09M	96.9M	90.95M	91.57M	95.01M
Other Operating Expenses	8.67M	13.64M	6.32M	9.32M	-348K
Other Operating Expenses, Total	384M	526M	512M	515M	503M
Operating Income	441M	375M	230M	267M	275M
Interest Expense, Total	-19.42M	-34.07M	-28.29M	-26.39M	-23.42M
Interest And Investment Income	284K	9.64M	15.37M	12.92M	8.48M
Net Interest Expenses	-19.13M	-24.43M	-12.92M	-13.47M	-14.94M
Income (Loss) On Equity Invest.	-	-	-	-	-
Currency Exchange Gains (Loss)	2M	-	-	-	-
Other Non Operating Income (Expenses)	-476K	-354K	-2.12M	-3.57M	-3.08M
EBT, Excl. Unusual Items	423M	350M	214M	250M	257M
Restructuring Charges	-	-	-	-	-
Merger & Related Restructuring Charges	-1.92M	-	-	-6.91M	-38.89M
Gain (Loss) On Sale Of Investments	-	-	-	-	-
Gain (Loss) On Sale Of Assets	-	-	-	-	-
Asset Writedown	-	-	-	-	-
Other Unusual Items	-21.9M	-24.06M	-13.25M	-329K	-6.15M
EBT, Incl. Unusual Items	399M	326M	201M	242M	212M
Income Tax Expense	88.6M	85.83M	42.71M	55.39M	61.57M
Earnings From Continuing Operations	311M	240M	159M	187M	150M
Net Income to Company	311M	240M	159M	187M	150M
Minority Interest	236K	797K	1.34M	1.05M	5.59M
Net Income - (IS)	311M	241M	160M	188M	156M
Net Income to Common Incl Extra Items	311M	241M	160M	188M	156M
Net Income to Common Excl. Extra Items	311M	241M	160M	188M	156M
Per Share Items
Net EPS - Basic	5.44	4.17	2.87	3.37	2.92
Basic EPS - Continuing Operations	5.44	4.17	2.87	3.37	2.92
Basic Weighted Average Shares Outstanding	57.12M	57.75M	55.75M	55.87M	53.3M
Net EPS - Diluted	5.4	4.15	2.87	3.37	2.85
Diluted EPS - Continuing Operations	5.4	4.15	2.87	3.37	2.85
Diluted Weighted Average Shares Outstanding	57.59M	58.05M	55.75M	55.87M	54.6M
Normalized Basic EPS	4.63	3.8	2.43	2.81	3.11
Normalized Diluted EPS	4.6	3.78	2.43	2.81	3.04
Dividend Per Share	1.05	1.1	1.15	1.2	1.3
Payout Ratio	17.59	23.68	36.89	32.58	40.83
American Depositary Receipts Ratio (ADR)	0.1	0.1	0.1	0.1	0.1
Supplemental Items
EBITDA	515M	482M	333M	365M	370M
EBITA	477M	434M	283M	323M	329M
EBIT	441M	375M	230M	267M	275M
Effective Tax Rate - (Ratio)	22.19	26.33	21.22	22.85	29.1
Total Current Taxes	92.75M	65.89M	57.89M	64.69M	51.7M
Total Deferred Taxes	-1.6M	22.99M	-12.99M	-7.94M	7.53M
Normalized Net Income	265M	220M	135M	157M	166M
Interest on Long-Term Debt	8.26M	12.26M	12.36M	13.48M	13.68M
Non-Cash Pension Expense	747K	206K	-	1.16M	-
Supplemental Operating Expense Items
Selling and Marketing Expenses	211M	292M	286M	288M	284M
General and Administrative Expenses	93.27M	123M	129M	128M	125M
Research And Development Expense From Footnotes	70.09M	96.9M	90.95M	91.57M	95.01M
Stock-Based Comp., G&A Exp. (Total)	6.43M	9.54M	10.04M	11.11M	11.11M
Stock-Based Comp., Other (Total)	-	-	-	-	-
Total Stock-Based Compensation	6.43M	9.54M	10.04M	11.11M	11.11M

Fiscal Period: December	2021	2022	2023	2024	2025
Assets
Cash And Equivalents	403M	242M	280M	344M	166M
Short Term Investments	-	142M	98.44M	34.65M	42.69M
Trading Asset Securities, Total	-	-	-	-	3.16M
Total Cash And Short Term Investments	403M	384M	379M	379M	212M
Accounts Receivable, Total	218M	220M	199M	195M	201M
Other Receivables	8.66M	21.32M	30.15M	9.42M	-
Total Receivables	226M	241M	229M	204M	201M
Inventory	298M	307M	316M	344M	335M
Other Current Assets, Total	30.97M	142M	59.73M	40.1M	38.14M
Total Current Assets	958M	1.07B	983M	967M	785M
Gross Property Plant And Equipment	524M	555M	-	-	622M
Accumulated Depreciation	-248M	-287M	-	-	-366M
Net Property Plant And Equipment	276M	268M	256M	271M	256M
Long-term Investments	26K	26K	26K	26K	26K
Goodwill	790M	826M	799M	847M	754M
Other Intangibles, Total	854M	836M	762M	753M	622M
Deferred Tax Assets Long-Term	38.23M	34.46M	31.81M	31.6M	36.85M
Deferred Charges Long-Term	285M	316M	339M	401M	393M
Other Long-Term Assets, Total	28.91M	52.34M	40.66M	34.64M	26.24M
Total Assets	3.23B	3.41B	3.21B	3.3B	2.87B
Liabilities
Accounts Payable, Total	84.77M	104M	101M	99.52M	109M
Accrued Expenses, Total	65.33M	67.68M	66.16M	73.91M	70.77M
Current Portion of Long-Term Debt	94.2M	112M	101M	38.43M	247M
Current Portion of Leases	9.64M	8.5M	8.91M	9.36M	10.16M
Current Income Taxes Payable	6.26M	13.79M	9.4M	18.07M	26.54M
Unearned Revenue Current, Total	-	-	-	-	-
Other Current Liabilities	38.03M	41.33M	34.2M	36.02M	42.13M
Total Current Liabilities	298M	347M	320M	275M	506M
Long-Term Debt	1.23B	1.17B	1.02B	899M	477M
Long-Term Leases	66.48M	61M	62.09M	67.36M	57.07M
Pension & Other Post Retirement Benefits	40.92M	32.48M	32.31M	31.94M	30.46M
Deferred Tax Liability Non Current	185M	229M	200M	200M	196M
Other Non Current Liabilities	43.98M	47.56M	38.44M	32.31M	29.69M
Total Liabilities	1.86B	1.89B	1.67B	1.51B	1.3B
Common Stock, Total	55.95M	55.95M	55.95M	55.95M	55.95M
Additional Paid In Capital	18.16M	18.16M	18.16M	18.16M	18.16M
Retained Earnings	1.3B	1.64B	1.76B	1.84B	2.03B
Treasury Stock	-120M	-281M	-297M	-252M	-343M
Comprehensive Income and Other	116M	84.73M	3.37M	136M	-174M
Total Common Equity	1.37B	1.52B	1.54B	1.8B	1.58B
Minority Interest	1.56M	761K	-643K	-1.9M	-7.69M
Total Equity	1.37B	1.52B	1.54B	1.8B	1.58B
Total Liabilities And Equity	3.23B	3.41B	3.21B	3.3B	2.87B
Supplemental Items
ECS Total Shares Outstanding on Filing Date	54.76M	53.52M	53.36M	53.89M	53M
ECS Total Common Shares Outstanding	54.75M	53.51M	53.36M	53.89M	53M
Book Value / Share	24.96	28.39	28.83	33.42	29.9
Tangible Book Value	-278M	-144M	-22.65M	201M	208M
Tangible Book Value Per Share	-5.07	-2.69	-0.42	3.74	3.93
Total Debt	1.4B	1.35B	1.19B	1.01B	791M
Net Debt	996M	968M	814M	636M	580M
Minority Interest, Total (Incl. Fin. Div)	1.56M	761K	-643K	-1.9M	-7.69M
Account Code - Inventory Valuation	5	5	5	5	5
Inventories - Raw Materials, Total	172M	170M	154M	179M	143M
Inventories - Work In Process, Total	82M	84.56M	82.22M	87.74M	86.82M
Inventories - Finished Goods, Total	93.82M	109M	110M	110M	130M
Inventories - Others	-	-20.92M	-	-	-
Land - (BS)	4.98M	5.16M	-	-	4.88M
Buildings, Total	35.56M	42.63M	-	-	54.3M
Machinery, Total	301M	318M	-	-	355M
Full Time Employees	3.31K	3.34K	3.18K	3.21K	3.21K
Part Time Employees	45	42	49	59	60
Accumulated Allowance for Doubtful Accounts (Supple)	11.97M	13.5M	11.25M	11.43M	11.26M

Fiscal Period: December	2021	2022	2023	2024	2025
Net Income	311M	241M	160M	188M	156M
Depreciation & Amortization - CF	47.11M	60.4M	61.83M	53.87M	53.75M
Amortization of Goodwill and Intangible Assets - (CF)	36.28M	58.94M	53.2M	55.99M	53.89M
Depreciation & Amortization, Total	83.39M	119M	115M	110M	108M
Amortization of Deferred Charges, Total - (CF)	12.61M	18.2M	21.86M	19.18M	20.61M
(Gain) Loss From Sale Of Asset	-384K	-	504K	1.8M	68K
Asset Writedown & Restructuring Costs	-	15.72M	-	-	-
Stock-Based Compensation (CF)	6.43M	9.54M	10.04M	11.04M	11.11M
Net Cash From Discontinued Operations	-	-	-	-	-
Other Operating Activities, Total	-3.62M	13.04M	5.72M	12.99M	-7.32M
Change In Accounts Receivable	-	-	-	-	-
Change In Inventories	-905K	-26.22M	-4.77M	-16.98M	34.06M
Change In Accounts Payable	6.79M	19.43M	-4.87M	1.57M	14.75M
Change in Other Net Operating Assets	-14.61M	-20.62M	8.32M	31.22M	6.21M
Cash from Operations	401M	389M	312M	359M	343M
Capital Expenditure	-68.48M	-53.2M	-45.47M	-52.12M	-61.73M
Sale of Property, Plant, and Equipment	6.94M	21.3M	5.1M	2.68M	5.28M
Cash Acquisitions	-1.5B	-	-	-	-
Divestitures	-	-	38.44M	-	-
Sale (Purchase) of Intangible assets	-48.9M	-60.49M	-67.77M	-67.59M	-75.95M
Investment in Marketable and Equity Securities, Total	-	-140M	40.6M	67.23M	-12.12M
Other Investing Activities, Total	-	-	-1K	-	1K
Cash from Investing	-1.61B	-232M	-29.1M	-49.81M	-145M
Long-Term Debt Issued, Total	1.32B	-	-	-	-
Total Debt Issued	1.32B	-	-	-	-
Long-Term Debt Repaid, Total	-	-116M	-158M	-235M	-191M
Total Debt Repaid	-	-116M	-158M	-235M	-191M
Issuance of Common Stock	-	-	-	37.56M	-
Repurchase of Common Stock	-8.58M	-160M	-18.53M	-	-96.28M
Common Dividends Paid	-54.71M	-57.05M	-58.97M	-61.28M	-63.54M
Common & Preferred Stock Dividends Paid	-54.71M	-57.05M	-58.97M	-61.28M	-63.54M
Special Dividend Paid	-	-	-	-	-
Other Financing Activities, Total	-1K	-	-	-	-1K
Cash from Financing	1.26B	-333M	-236M	-259M	-351M
Foreign Exchange Rate Adjustments	17.18M	14.41M	-8.06M	14.11M	-25.54M
Miscellaneous Cash Flow Adjustments	-	-	-1K	-	-1K
Net Change in Cash	63.14M	-161M	38.54M	63.96M	-178M
Supplemental Items
Cash Income Tax Paid (Refund)	118M	91.56M	37.09M	33.14M	47.38M
Levered Free Cash Flow	106M	144M	229M	203M	229M
Unlevered Free Cash Flow	118M	166M	247M	220M	244M
Change In Net Working Capital	143M	102M	-69.55M	-32.73M	-70.2M
Net Debt Issued / Repaid	1.32B	-116M	-158M	-235M	-191M

Fiscal Period: December	2021	2022	2023	2024	2025
Profitability
Return on Assets	12.3	7.06	4.33	5.12	5.56
Return on Total Capital	14.66	8.31	5.12	6.01	6.63
Return On Equity %	26.74	16.63	10.37	11.21	8.89
Return on Common Equity	26.8	16.7	10.46	11.27	9.19
Margin Analysis
Gross Profit Margin %	66.64	66.17	64.55	65.99	65.06
SG&A Margin	24.66	30.51	36.09	34.98	34.16
EBITDA Margin %	41.63	35.41	29.04	30.79	30.96
EBITA Margin %	38.54	31.86	24.62	27.22	27.49
EBIT Margin %	35.61	27.53	19.99	22.5	22.98
Income From Continuing Operations Margin %	25.11	17.64	13.8	15.78	12.55
Net Income Margin %	25.13	17.7	13.92	15.87	13.02
Net Avail. For Common Margin %	25.13	17.7	13.92	15.87	13.02
Normalized Net Income Margin	21.39	16.13	11.79	13.25	13.89
Levered Free Cash Flow Margin	8.53	10.59	19.94	17.16	19.15
Unlevered Free Cash Flow Margin	9.51	12.16	21.48	18.55	20.38
Asset Turnover
Asset Turnover	0.55	0.41	0.35	0.36	0.39
Fixed Assets Turnover	5.94	5	4.38	4.49	4.53
Receivables Turnover (Average Receivables)	6.46	6.22	5.49	6.03	6.04
Inventory Turnover (Average Inventory)	1.69	1.52	1.31	1.22	1.23
Short Term Liquidity
Current Ratio	3.21	3.1	3.07	3.51	1.55
Quick Ratio	2.11	1.8	1.9	2.12	0.82
Operating Cash Flow to Current Liabilities	1.34	1.12	0.97	1.3	0.68
Days Sales Outstanding (Average Receivables)	56.51	58.68	66.53	60.71	60.38
Days Outstanding Inventory (Average Inventory)	216.27	239.58	278.89	299.34	296.62
Average Days Payable Outstanding	52.77	73.54	89.89	84.87	93.16
Cash Conversion Cycle (Average Days)	220.02	224.71	255.53	275.18	263.85
Long Term Solvency
Total Debt/Equity	102.24	88.96	77.55	56.4	50.19
Total Debt / Total Capital	50.55	47.08	43.68	36.06	33.42
LT Debt/Equity	94.65	81.06	70.42	53.74	33.86
Long-Term Debt / Total Capital	46.8	42.9	39.66	34.36	22.54
Total Liabilities / Total Assets	57.66	55.41	52.11	45.57	45.12
EBIT / Interest Expense	22.7	11	8.11	10.11	11.73
EBITDA / Interest Expense	26.99	14.5	12.18	14.27	16.33
(EBITDA - Capex) / Interest Expense	23.47	12.94	10.57	12.29	13.69
Total Debt / EBITDA	2.67	2.74	3.46	2.69	2.07
Net Debt / EBITDA	1.9	1.96	2.36	1.69	1.52
Total Debt / (EBITDA - Capex)	3.07	3.07	3.99	3.13	2.47
Net Debt / (EBITDA - Capex)	2.18	2.19	2.72	1.96	1.81
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	40.43	9.98	-15.64	3.24	0.81
Gross Profit, 1 Yr. Growth %	36.8	9.2	-17.7	5.54	-0.54
EBITDA, 1 Yr. Growth %	37.38	-6.46	-30.82	6.47	1.51
EBITA, 1 Yr. Growth %	37.38	-9.08	-34.82	10.49	1.97
EBIT, 1 Yr. Growth %	33.7	-14.97	-38.76	11.65	3.18
Earnings From Cont. Operations, 1 Yr. Growth %	25.15	-22.73	-33.99	18.01	-19.79
Net Income, 1 Yr. Growth %	25.46	-22.53	-33.65	17.68	-17.27
Normalized Net Income, 1 Yr. Growth %	29.69	-16.68	-38.34	11.74	5.88
Diluted EPS Before Extra, 1 Yr. Growth %	20	-23.15	-30.9	17.42	-15.35
Accounts Receivable, 1 Yr. Growth %	31.33	1.12	-9.76	-1.95	3.08
Inventory, 1 Yr. Growth %	55.86	2.84	2.94	9.05	-2.74
Net Property, Plant and Equip., 1 Yr. Growth %	96.59	-2.81	-4.53	5.88	-5.71
Total Assets, 1 Yr. Growth %	159.23	5.48	-5.77	2.91	-13.06
Tangible Book Value, 1 Yr. Growth %	-140.41	-48.2	-84.25	-988.83	3.36
Common Equity, 1 Yr. Growth %	43.12	11.17	1.29	17.05	-12.02
Cash From Operations, 1 Yr. Growth %	31.55	-2.83	-19.95	15.12	-4.47
Capital Expenditures, 1 Yr. Growth %	61.2	-22.32	-14.53	14.64	18.43
Levered Free Cash Flow, 1 Yr. Growth %	-43.86	38.65	58.8	-13.46	35.93
Unlevered Free Cash Flow, 1 Yr. Growth %	-38.01	40.64	49.05	-12.99	31.72
Dividend Per Share, 1 Yr. Growth %	5	4.76	4.55	4.35	8.33
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	32.37	24.28	-3.68	-6.68	2.02
Gross Profit, 2 Yr. CAGR %	29.91	22.22	-5.2	-6.8	2.42
EBITDA, 2 Yr. CAGR %	38.33	13.36	-19.56	-12.98	3.89
EBITA, 2 Yr. CAGR %	41.12	11.76	-23.02	-13.74	6.06
EBIT, 2 Yr. CAGR %	40.94	6.62	-27.84	-15.64	7.23
Earnings From Cont. Operations, 2 Yr. CAGR %	32.97	-1.66	-28.58	-11.74	-2.71
Net Income, 2 Yr. CAGR %	33.02	-1.41	-28.3	-11.64	-1.33
Normalized Net Income, 2 Yr. CAGR %	38.47	3.71	-28.32	-15.41	8.66
Diluted EPS Before Extra, 2 Yr. CAGR %	29.9	-3.97	-27.13	-9.93	-0.3
Accounts Receivable, 2 Yr. CAGR %	28.14	15.24	-4.47	-5.93	0.54
Inventory, 2 Yr. CAGR %	31.97	26.6	2.89	5.95	2.98
Net Property, Plant and Equip., 2 Yr. CAGR %	46.67	38.23	-3.67	0.54	-0.08
Total Assets, 2 Yr. CAGR %	74.3	65.36	-0.31	-1.53	-5.41
Tangible Book Value, 2 Yr. CAGR %	-29.36	-54.25	-71.44	18.32	203.1
Common Equity, 2 Yr. CAGR %	26.89	26.14	6.12	8.89	1.48
Cash From Operations, 2 Yr. CAGR %	31.23	13.06	-11.8	-4	4.87
Capital Expenditures, 2 Yr. CAGR %	35.26	11.9	-18.52	-1.01	16.52
Levered Free Cash Flow, 2 Yr. CAGR %	-11.43	-12.42	48.38	18.76	-1.31
Unlevered Free Cash Flow, 2 Yr. CAGR %	-7.23	-6.63	44.78	15.26	-1.83
Dividend Per Share, 2 Yr. CAGR %	5.13	4.88	4.65	4.45	6.32
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	22.75	24.44	9.22	-1.43	-4.24
Gross Profit, 3 Yr. CAGR %	21.86	22.6	7.13	-1.75	-4.78
EBITDA, 3 Yr. CAGR %	26.82	21.42	-3.85	-10.86	-8.44
EBITA, 3 Yr. CAGR %	28.65	21.89	-6.62	-12.21	-8.84
EBIT, 3 Yr. CAGR %	28.61	19.09	-11.37	-15.42	-9.84
Earnings From Cont. Operations, 3 Yr. CAGR %	25.25	10.96	-13.9	-15.56	-14.51
Net Income, 3 Yr. CAGR %	25.29	11.09	-13.6	-15.43	-13.55
Normalized Net Income, 3 Yr. CAGR %	27.58	16.72	-12.79	-15.84	-8.9
Diluted EPS Before Extra, 3 Yr. CAGR %	23.76	9.05	-13.95	-14.57	-11.77
Accounts Receivable, 3 Yr. CAGR %	18.4	18.42	6.22	-3.64	-3.02
Inventory, 3 Yr. CAGR %	22.94	21.44	18.16	4.9	2.97
Net Property, Plant and Equip., 3 Yr. CAGR %	42.73	27.87	22.19	-0.59	-1.59
Total Assets, 3 Yr. CAGR %	52.79	47.43	37.09	0.76	-5.53
Tangible Book Value, 3 Yr. CAGR %	-11.56	-36.3	-67.93	-10.16	13.11
Common Equity, 3 Yr. CAGR %	24.69	21.42	17.24	9.64	1.42
Cash From Operations, 3 Yr. CAGR %	24.05	18.72	0.77	-3.61	-4.16
Capital Expenditures, 3 Yr. CAGR %	27.23	12.43	2.29	-8.69	5.08
Levered Free Cash Flow, 3 Yr. CAGR %	-4.65	2.34	6.8	25.05	16.65
Unlevered Free Cash Flow, 3 Yr. CAGR %	-1.79	6.57	9.12	23.17	13.74
Dividend Per Share, 3 Yr. CAGR %	5.27	5.01	4.77	4.55	5.73
Compound Annual Growth Rate Over Five Years
Total Revenues, 5 Yr. CAGR %	16.8	16.38	11.4	10.91	6.28
Gross Profit, 5 Yr. CAGR %	16.21	15.83	10.21	9.86	5.22
EBITDA, 5 Yr. CAGR %	18.88	14.71	5.71	6.27	-0.27
EBITA, 5 Yr. CAGR %	20.24	15.28	4.76	6.14	-1.1
EBIT, 5 Yr. CAGR %	19.95	13.75	2.07	3.75	-3.59
Earnings From Cont. Operations, 5 Yr. CAGR %	22.51	11.41	0.05	1.26	-9.58
Net Income, 5 Yr. CAGR %	22.58	11.49	0.22	1.37	-8.89
Normalized Net Income, 5 Yr. CAGR %	19.55	13.02	1.21	2.62	-4.05
Diluted EPS Before Extra, 5 Yr. CAGR %	21.49	10.32	0.13	1.02	-8.73
Accounts Receivable, 5 Yr. CAGR %	12.59	11.3	8.66	8	3.91
Inventory, 5 Yr. CAGR %	18.26	16.5	14.49	14.99	11.84
Net Property, Plant and Equip., 5 Yr. CAGR %	24.55	23.79	21.96	16.15	12.74
Total Assets, 5 Yr. CAGR %	30.05	29.23	28.8	25.45	18.18
Tangible Book Value, 5 Yr. CAGR %	-5.55	-20.57	-43.73	-18.4	-21.25
Common Equity, 5 Yr. CAGR %	15.57	15.42	16.9	16.24	10.66
Cash From Operations, 5 Yr. CAGR %	19.33	18.38	8.23	9.05	2.39
Capital Expenditures, 5 Yr. CAGR %	17.93	9.84	6.46	6.85	7.76
Levered Free Cash Flow, 5 Yr. CAGR %	1.7	7.08	13.47	8.61	4.02
Unlevered Free Cash Flow, 5 Yr. CAGR %	3.61	9.56	14.7	9.96	5.11
Dividend Per Share, 5 Yr. CAGR %	5.59	5.29	5.02	4.78	5.39